Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Mandarin

THURSDAY —

22

SATURDAY

,

2014
O r i e n t a l W ASHINGTON , DC

February 20

MedStar Georgetown University H...
LOCAL TREATMENT,
PREVENTION,
RECONSTRUCTION
■

■

■

■

■

Tumor Board Panel
Managing Lymphedema

■

Management of Breast ...
CONFERENCE CO-CHAIRS

FA C U LT Y

continued

Juliann Reiland, MD
Avera Medical Group, Comprehensive Breast Care
Sioux Fal...
Thursday
11:00 - 11:45

Symposium - TBA

12:00 - 12:45

20 February 2014

Lunch Symposium - TBA
BREAST CONSERVATION THERAP...
Friday

21 February 2014

7:30 - 9:00

Breakfast / Exhibits / Faculty Booth

7:45 - 8:45

12:30 - 1:15

Breakfast Symposiu...
Saturday
7:00 - 8:00

Breakfast

7:00 - 7:45

22 February 2014

Breakfast Symposium - TBA

STEM CELLS, FAT, AND ACELLULAR
...
TA R G E T A U D I E N C E :
General, Plastic, Breast and Oncologic Surgeons
Radiation and Medical Oncologists ✦ Primary C...
CONFERENCE REGISTRATION FEBRUARY 20 – 22, 2014
M ANDARIN O RIENTAL WASHINGTON , DC

BC3
Breast Cancer
Coordinated Care
NAM...
Upcoming SlideShare
Loading in …5
×

BC3 Breast Cancer Coordinated Care Conference

708 views

Published on

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

BC3 Breast Cancer Coordinated Care Conference

  1. 1. Mandarin THURSDAY — 22 SATURDAY , 2014 O r i e n t a l W ASHINGTON , DC February 20 MedStar Georgetown University Hospital 3800 Reservoir Rd. NW Washington, DC 20007 Coordinated CarE Breast Cancer BC3 Nashville, TN Permit NO. 4398 PAID U.S. Postage NON PROFIT ORG. WWW.BC3CONFERENCE.COM U P D A T E D MANDARIN ORIENTAL CO-CHAIRS: SCOTT L. SPEAR, MD p r o g r a m 3 BC Breast Cancer Coordinated Care MEDSTAR GEORGETOWN UNIVERSITY HOSPITAL FEBRUARY 20-22, 2014 WASHINGTON, DC ■ SHAWNA C. WILLEY, MD BC3 CONFERENCE . COM
  2. 2. LOCAL TREATMENT, PREVENTION, RECONSTRUCTION ■ ■ ■ ■ ■ Tumor Board Panel Managing Lymphedema ■ Management of Breast Cancer in the Augmented Breast Strategies in Working Up Breast Cancer and Reconstruction Planning ■ Nipple-Sparing Mastectomy: Prophylactic and Therapeutic Coordinating Reconstruction with Post-Mastectomy XRT Coordinating Flap Reconstruction with PostMastectomy Radiation When to Delay Breast Reconstruction Breast Cancer in the Obese Patient ■ Stem Cells, Fat, and Acellular Tissue Matrices ■ Incorporating Oncoplastic Surgery in your Practice Reducing Flap Necrosis ■ ■ ■ Coordinating Breast Conservation and Intraoperative Radiation Therapy ■ Breast Reconstruction in the Ptotic or Large Breast CALL FOR POSTER ABSTRACTS Deadline January 9, 2014 Registration Hours Thursday 8:00 AM - 7:00 PM Friday 7:00 AM - 5:00 PM Saturday 6:30 AM - 12:30 PM 14.5 CMEs Exhibit Hours Thursday 3:00 - 7:30 PM Friday 7:30 AM - 4:00 PM
  3. 3. CONFERENCE CO-CHAIRS FA C U LT Y continued Juliann Reiland, MD Avera Medical Group, Comprehensive Breast Care Sioux Falls, SD Jennifer Rusby, MD Royal Marsden Hospital Sutton, UK Scott L. Spear, MD Professor and Chairman Department of Plastic Surgery Shawna C. Willey, MD Associate Professor of Clinical Surgery Vice-Chairman of Clinical Affairs, Department of Surgery Alan Stolier, MD St. Charles Surgical Hospital New Orleans, LA Eric A. Strom, MD University of Texas MD Anderson Cancer Center Houston, TX C. Andrew Salzberg, MD New York Group for Plastic Surgery Tarrytown, NY MedStar Georgetown University Hospital • Washington, DC Hani Sbitany, MD University of California, San Francisco San Francisco, CA FA C U LT Y Michael Scheflan, MD Private Practice Tel Aviv, Israel Tanir M. Allweis, MD Kaplan Medical Center and Hebrew University School of Medicine Jerusalem & Rehovot, Israel Peter G. Cordeiro, MD Memorial Sloan-Kettering Cancer Center New York, NY Dennis R. Holmes, MD Los Angeles Center for Women’s Health Los Angeles, CA Kelly K. Hunt, MD University of Texas MD Anderson Cancer Center Houston, TX Joseph H. Dayan, MD Beth Israel Medical Center New York, NY Steven J. Kronowitz, MD University of Texas MD Anderson Cancer Center Houston, TX Prof. J. Michael Dixon, OBE University of Edinburgh Edinburgh, Scotland Albert Losken, MD Emory University Atlanta, GA Allen Gabriel, MD PeaceHealth Medical Group Loma Linda University Medical Center Vancouver, WA & Loma Linda, CA R. Douglas MacMillan, MD Nottingham Breast Institute City Hospital Nottingham, UK Armando E. Giuliano, MD Cedars-Sinai Medical Center Los Angeles, CA Maurice Y. Nahabedian, MD MedStar Georgetown University Hospital Washington, DC Jane Grayson, MD Inova Alexandria Hospital Alexandria, VA John B. Hijjawi, MD Medical College of Wisconsin Milwaukee, WI Bridget A. Oppong, MD MedStar Georgetown University Hospital Washington, DC Beth N. Peshkin, MS, CGC Georgetown Lombardi Comprehensive Cancer Center Washington, DC Melvin J. Silverstein, MD Hoag Memorial Hospital Presbyterian & Keck School of Medicine University of Southern California Newport Beach & Los Angeles, CA Sumner A. Slavin, MD Harvard Medical School Boston, MA Barbara L. Smith, MD, PhD Massachusetts General Hospital Boston, MA Lorraine Tafra, MD Anne Arundel Hospital & Johns Hopkins Hospital Annapolis, MD Eleni Tousimis, MD MedStar Georgetown University Hospital Washington, DC Frank A. Vicini, MD 21st Century Oncology / Michigan Healthcare Professionals Farmington Hills, MI Julia R. White, MD The Ohio State University Comprehensive Cancer Center Columbus, OH Pat W. Whitworth, MD Nashville Breast Center Nashville, TN
  4. 4. Thursday 11:00 - 11:45 Symposium - TBA 12:00 - 12:45 20 February 2014 Lunch Symposium - TBA BREAST CONSERVATION THERAPY AND ONCOPLASTIC SURGERY 1:00 - 1:05 1:05 - 1:20 1:20 - 1:35 1:35 - 1:50 Welcoming Remarks Scott L. Spear, MD and Shawna C. Willey, MD Our Experience with Oncoplastic Surgery and Breast Conservation Therapy Focusing on Delayed Reconstruction (MD Anderson Team) Steven J. Kronowitz, MD 5:00 - 5:10 The Previously Augmented Breast from the Breast Surgeon’s Perspective Pat W. Whitworth, MD 5:10 - 5:20 The Previously Augmented Breast from the Radiation Oncologist’s Perspective Frank A. Vicini, MD 5:20 - 5:30 The Previously Augmented Breast from the Plastic Surgeon’s Perspective Sumner A. Slavin, MD 5:30 - 5:40 The Obese Patient from the Plastic Surgeon’s Perspective Albert Losken, MD Our Experience with Oncoplastic Surgery and Breast Conservation Therapy Focusing on the Patient with Multiple Tumors (Edinburgh Team) Prof. J. Michael Dixon, OBE 5:40 - 5:50 The Obese Patient from the Breast Surgeon’s Perspective Juliann Reiland, MD Our Experience with Oncoplastic Surgery and Breast Conservation Therapy with Focus on Immediate Flap Reconstruction (Nottingham Team) R. Douglas MacMillan, MD 6:00 - 6:30 Panel Discussion / Q & A Moderator: Armando E. Giuliano, MD 1:50 - 2:05 Our Experience with Oncoplastic Surgery and Breast Conservation Therapy (Emory Team) Albert Losken, MD 2:05 - 2:20 Delayed Immediate Oncoplastic Reconstruction Maurice Y. Nahabedian, MD 2:20 - 2:35 Our Experience with Oncoplastic Surgery and Breast Conservation Therapy Melvin J. Silverstein, MD 2:35 - 3:00 Panel Discussion / Q & A Moderator: Dennis R. Holmes, MD 3:00 - 3:45 Break / Exhibits / Faculty Booth MOCK ONCOPLASTIC TUMOR BOARD PANEL Moderator: Prof. J. Michael Dixon, OBE 3:45 - 4:00 4:00 - 4:15 4:15 - 4: 30 4:30 - 4:45 4:45 - 5:00 SPECIAL SURGICAL CHALLENGES IN THE MANAGEMENT OF BREAST CANCER MD Anderson Team Kelly K. Hunt, MD Community Team Juliann Reiland, MD Nottingham Team R. Douglas MacMillan, MD Israeli Team Tanir M. Allweis, MD Silverstein’s Team Melvin J. Silverstein, MD 5:50 - 6:00 The Obese Patient from the Radiation Oncologist’s Perspective Julia R. White, MD 6:30 - 7:30 Reception with Exhibitors
  5. 5. Friday 21 February 2014 7:30 - 9:00 Breakfast / Exhibits / Faculty Booth 7:45 - 8:45 12:30 - 1:15 Breakfast Symposium - TBA Lunch Symposium – TBA NIPPLE-SPARING THERAPEUTIC MASTECTOMY NIPPLE-SPARING MASTECTOMY 1:35 - 1:50 Update on Imaging and Planning: 3D Mammography, MRI, & Other Technologies Lorraine Tafra, MD 9:00 - 9:10 Genetic Counseling Including New Genetic Tests Beth N. Peshkin, MS, CGC 1:50 - 2:05 The Evidence on the Oncologic Safety of Therapeutic Nipple-Sparing Mastectomy Barbara L. Smith, MD, PhD 9:10 - 9:20 Prophylactic Mastectomy in the Non-Gene Mutation Carrier Jennifer Rusby, MD 2:05 - 2:20 Managing the Positive Margin after Therapeutic Nipple-Sparing Mastectomy: My Data and Experience Armando E. Giuliano, MD 9:20 - 9:30 The Evidence on the Oncologic Safety of Prophylactic NSM Kelly K. Hunt, MD 2:20 - 2:35 My Experience with Therapeutic Nipple-Sparing Mastectomy in the Patient Who Receives Post-Mastectomy XRT Hani Sbitany, MD 9:30 - 9:40 The Lateral Approach for NSM 2:35 - 2:50 9:40 - 9:50 The IMF Approach for NSM NSM in the Previously Radiated Patient: Pros and Cons Eleni Tousimis, MD 9:50 - 10:00 Lessons Learned in Reducing Complications with NSM Armando E. Giuliano, MD 2:50 - 3:10 Panel Discussion / Q & A Moderator: Bridget A. Oppong, MD 3:10 - 3:45 Break / Exhibits / Faculty Booth Barbara L. Smith, MD, PhD Pat W. Whitworth, MD 10:00 - 10:10 My Approach to Avoid Nipple and Flap Necrosis Alan Stolier, MD 10:10 - 10:30 Panel Discussion / Q & A Moderator: Eleni Tousimis, MD POST-MASTECTOMY RADIATION THERAPY 3:45 - 4:00 Indications for Post-Mastectomy XRT 4:00 - 4:15 Is PMRT Necessary with a Complete Pathologic Response after Neoadjuvant Chemotherapy? Julia R. White, MD 11:10 - 11:25 My Algorithm and Approach for Direct to Implant Reconstruction C. Andrew Salzberg, MD 4:15 - 4:30 Radiation Planning and the Reconstructed Breast Frank A. Vicini, MD 11:25 - 11:40 My Algorithm and Approach to Expander/Implant Reconstructions Peter G. Cordeiro, MD 4:30 - 4:45 11:40 - 12:00 Managing Flap Necrosis and Nipple Necrosis and the Failed Implant Reconstruction Scott L. Spear, MD Lymphedema after BCT, Mastectomy, Axillary Dissection, and/or XRT: How Frequent? How Serious? How to Diagnose? Pat W. Whitworth, MD 4:45 - 5:00 12:00 - 12:20 Panel Discussion / Q & A Moderator: Sumner A. Slavin, MD Update on the Surgical Management of Lymphedema Joseph H. Dayan, MD 5:00 - 5:30 Panel Discussion / Q & A Moderator: Kelly K. Hunt, MD 5:30 - 6:30 Poster Abstract Review with Authors 10:30 - 11:10 Break / Exhibits / Faculty Booth ONE-STAGE OR TWO-STAGE BREAST RECONSTRUCTION 12:20 - 1:35 Lunch / Exhibits / Faculty Booth Jane Grayson, MD
  6. 6. Saturday 7:00 - 8:00 Breakfast 7:00 - 7:45 22 February 2014 Breakfast Symposium - TBA STEM CELLS, FAT, AND ACELLULAR TISSUE MATRICES 10:30 - 10:45 A Plastic Surgeon’s Experience with Fat as an Adjunct to Breast Reconstruction Including BCT/XRT John B. Hijjawi, MD 10:45 - 11:00 A Breast Surgeon’s Perspective on Fat as an Adjunct to Breast Reconstruction Prof. J. Michael Dixon, OBE 11:00 - 11:15 Acellular Tissue Matrix Options in Immediate Breast Reconstruction Michael Scheflan, MD 11:15 - 11:30 Selective Use of ADMs in Immediate Breast Reconstruction Hani Sbitany, MD 11:30 - 11:45 The Science Behind Fat Grafting and ADMs Steven J. Kronowitz, MD 11:45 - 12:00 Acellular Tissue Matrices: To Use or Not, What Is the Evidence? Maurice Y. Nahabedian, MD 12:00 - 12:30 Panel Discussion / Q & A Moderator: Scott L. Spear, MD IORT AND COORDINATING RECONSTRUCTION WITH POST-MASTECTOMY XRT 8:00 - 8:15 Coordinating Reconstruction and Post-Mastectomy Radiation Therapy Eric A. Strom, MD 8:15 - 8:30 The Argument for Exchange of Expander to Implant Pre XRT Peter G. Cordeiro, MD 8:30 - 8:45 The Argument for Exchange of Expander to Implant Post XRT Allen Gabriel, MD 8:45 - 9:00 9:00 - 9:15 Delayed Immediate Reconstruction and XRT: An Update Steven J. Kronowitz, MD Update on IORT Data Dennis R. Holmes, MD 9:15 - 9:30 IORT and Oncoplastic Surgery? Melvin J. Silverstein, MD 9:30 - 10:00 Panel Discussion / Q & A Moderator: Eric A. Strom, MD 10:00 - 10:30 Break
  7. 7. TA R G E T A U D I E N C E : General, Plastic, Breast and Oncologic Surgeons Radiation and Medical Oncologists ✦ Primary Care Physicians Oncology Nurses & Practitioners ✦ Genetic Counselors Hospital Administrators Accreditation Statement: MedStar Georgetown University Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Medstar Georgetown University Hospital designates this educational activity for a maximum of 14.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Disclosure of Financial Relationships with Any Commercial Interest As a sponsor accredited by the ACCME, it is the policy of MedStar Georgetown University Hospital to require that everyone who is in the position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest prior to the educational activity. The ACCME considers relationship of the person involved in the CME activity to include financial relationship of a spouse or partner. Faculty and planners who refuse to disclose relevant financial relationships will be disqualified from participating in the CME activity. For an individual with no relevant financial relationship(s), the participant must be informed that no conflicts of interest or financial relationship(s) exist. MedStar Georgetown University Hospital Department of Nursing Education is an approved provider of continuing nursing education by the Maryland Nurses Association, an accredited provider by the American Nurses Credentialing Center’s Commission on accreditation. Nurses will be awarded a maximum of 14.5 contact hours for successfully completing the program. Conference Objectives: Following this program, participants should have a thorough understanding of the important controversial aspects of coordinated local treatment of breast cancer and breast reconstruction. They will be aware of the pros and cons regarding prophylactic mastectomy, as well as the pros and cons regarding nipple-sparing in both prophylactic and therapeutic mastectomy. They will understand surgical techniques designed to improve the likelihood of nipple preservation and reduce the risk of flap or nipple necrosis with mastectomy. They will have a more complete understanding of the impact of reconstruction on post-mastectomy radiation delivery and, conversely, of the impact of post-mastectomy radiation on prior reconstruction. They will learn different philosophies regarding radiation delivery including new techniques and how to minimize side effects to the surrounding tissue. They will obtain a better understanding of the arguments regarding re-staging patients after neoadjuvant chemotherapy and the pros and cons of downstaging based upon response to chemotherapy pre-mastectomy on the subsequent treatment plan, the scope and power of oncoplastic surgery in the patient who undergoes breast conservation therapy for breast cancer, and the arguments in favor of a coordinated team approach in oncoplastic surgery to maximize the cosmetic and oncologic outcomes. Attendees will also become familiar with different methods of breast reconstruction including implantbased reconstruction, flap-based reconstruction, and microsurgical-assisted free flap reconstruction. They will become aware of the proper patient selection and timing for these procedures as well as the evolving role of alloplastic materials in breast reconstruction both in terms of enhancing and facilitating device reconstruction of the breast, as well as reconstructing the abdomen after flap harvesting. Target Audience: This program is specifically designed to be a multidisciplinary program and is intended for a wide range of medical practitioners who are interested in the latest information regarding the local treatment of breast cancer. The program is purposely targeted for general, plastic, breast and oncologic surgeons, as well as radiation & medical oncologists. It is also intended for primary care physicians, oncology nurses and practitioners, genetic counselors and hospital administrators who have an interest in the treatment of breast cancer patients. Course Description: Breast cancer is the most common cancer affecting women. Its diagnosis and treatment are part of the practice of a wide number of medical specialties including primary care physicians, medical oncologists, surgical oncologists, breast surgeons, plastic surgeons, radiation oncologists, psychologists and other healthcare professions. There are national initiatives calling for a multidisciplinary approach to the care of these patients. The multiple components and aspects of the treatment of breast cancer require a high level of coordinated care among different specialties. This coordination becomes even more challenging because of the rapid evolution of new treatment modalities and is especially important because of the possibility of improved outcomes both in terms of curing the disease, as well as maintaining the physical and psychological well-being of the patient. This meeting is the first of its kind to assemble an international faculty of specialists focused on the local treatment of breast cancer including breast surgeons, plastic surgeons and radiation oncologists. The intent of the meeting is to present a range of treatment options and points of view from different specialties regarding specific controversial areas of treatment. The meeting will offer presentations and panel discussions on a number of currently important topics in the local treatment of breast cancer including oncoplastic surgery, the role of prophylactic mastectomy, the state of partial breast irradiation, intraoperative radiation therapy, timing and indications for post-mastectomy radiation, neoadjuvant chemotherapy and its role in restaging breast cancer, nipple-sparing mastectomy both therapeutic and prophylactic, treatment of breast cancer in a previously augmented breast, the status of MRI screening for breast cancer, the effects of reconstruction on the delivery of post-mastectomy radiation, and the evolving role of alloplastic materials in breast reconstruction. Attendees will hear different models for coordination of breast cancer from major centers across the USA. They will also hear arguments for and against treatments such as nipple-sparing mastectomy in the patient with breast cancer and the timing of reconstruction vis-a-vis postmastectomy radiation therapy. The meeting’s intent is not only to educate the faculty and attendees about the wide range of options available for breast cancer coordinated care, but also to encourage the development of more standardized treatment strategies and protocols in the local treatment of breast cancer. Acknowledgment: This continuing medical education activity is supported by unrestricted educational grants and exhibitor & commercial support from contributing organizations, each of which will be identified in course materials at the conference. Advisory: Certificates of Attendance for CMEs and Contact hours are available for you to print online during and after this conference. Attendees can update or edit their Attendance Checklist or CME Certificate through March 17, 2014. After that time, no further changes can be made on the forms. Certificates can be printed for a period of two years.
  8. 8. CONFERENCE REGISTRATION FEBRUARY 20 – 22, 2014 M ANDARIN O RIENTAL WASHINGTON , DC BC3 Breast Cancer Coordinated Care NAME PLEASE PRINT TITLE / DEGREE SPECIALTY: POSITION General Surgery Med Onc PCP Oncology Breast Plastic Surgery Rad Onc Other ______________________ A F F I L I AT I O N / I N S T I T U T I O N STREET ADDRESS ADDRESS LINE 2 CITY ZIP CODE STATE/PROV COUNTRY PHONE EMAIL (required for confirmation) REGISTRATION FEES 10/1/13 MDs/DOs RNs/NPs/Allied Health Professionals TO 11/30/13 12/1/13 $775 $525 Residents / Students* $250 Industry 2/19/14 ONSITE $950 $650 $900 Military TO $875 $600 $450 (*Proof Required) MDs – One Day BC3 CONFERENCE HOTEL $375 Check One: Thur. Fri. Sat. RNs/Allied Health Professionals – One Day $325 Check One: Thur. Fri. Sat. GUEST FEES Mandarin Oriental Wa s h i n g to n , D C Companion Reception $200 Includes Welcome Reception, All Conference Meals and Access to Exhibits $50 Includes Welcome Reception ◆ GUEST NAME _______________________________ REGISTRATION INCLUDES ◆ Tuition ◆ Online Course Webcast (post con) ◆ CMEs / Contact Hours ◆ Welcome Reception ◆ All Conference Meals Modern luxury in the nation’s capital The hotel’s unique location on the southwest waterfront makes Mandarin Oriental, Washington D C the only hotel offering views of the Jefferson Memorial and Washington Monument, Tidal Basin and Washington Marina. Close to both Capitol Hill and the Smithsonian Institute, the hotel exudes a refined sense of style with beautifully designed rooms, a serene spa, excellent restaurants and legendary service. Blending Oriental elegance with traditional American style, every guest room boasts a spectacular view of tranquil water or historic monuments. CANCELLATION POLICY If your registration must be cancelled, the course fee less $150 administrative costs will be refunded if we are notified in writing by January 1, 2014. After January 1, 2014, no refunds will be given. PAYMENT METHOD Enclosed is a check in the amount of $____________ (Please make checks payable to MedStar Georgetown University Hospital) Charge my credit card the amount of $__________ Visa MasterCard American Express Discover Charge will appear as ICMMEETINGS COM Card#___________________________________________________________ Exp. Date _____/______ Security Code #__________ Cardholder’s Name (please print)_____________________________________________________________________________________ Signature________________________________________________________________________________________________________ 1330 Mar yland Ave SW • Washington, DC • 202-787-6140 Register online at www.BC3conference.com or Fax to: 337-235-7300 BC3 Hotel Rate - $279 Single or Double Mention "Breast Cancer Coordinated Care" to receive the group rate. Y O U W I L L R E C E I V E A N E M A I L C O N F I R M AT I O N O F Y O U R R E G I S T R AT I O N MAIL TO: BC3 ADMINISTRATIVE HEADQUARTERS • 2701 JOHNSTON STREET • SUITE 201• LAFAYETTE, LA 70503 WWW.BC3CONFERENCE.COM FAX: 337.235.7300 • TEL: 337.235.6606 • registration@BC3conference.com • www.BC3conference.com CONFERENCE MANAGEMENT BC3 Conference Headquarters ■ 2701 Johnston Street, Suite 201 ■ Lafayette, LA 70503 Tel: 337.235.6606 ■ Fax: 337.235.7300 ■ info@BC3conference.com CONFERENCE HOTEL • MANDARIN ORIENTAL WASHINGTON, DC 1330 Maryland Ave. SW • Washington, DC 20024 • Reservations 866-926-3713 • 202-787-6140 BC3 Hotel Rate - $279 Single or Double • Mention “Breast Cancer Coordinated Care” to receive the group rate.

×